ENvue Medical, Inc. - FEED
Detailed investor-level table based on 13F positions.
Early Q4 2025 data: only 6 institutional holders reported so far. The full shareholder list will grow as more funds file with the SEC.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | History | New | 250,899 | 225 | 0.0% | — | 1 | +250,899 | New | Q1 2024 | May 15, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | History | Reduced | 38,862 | 35 | 0.0% | 0.0% | 2 | -2,338 | -5.67% | Q1 2024 | May 13, 2024 |
| VANGUARD GROUP INC | History | No change | 30,194 | 27 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q1 2024 | May 10, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | History | No change | 14,461 | 12 | 0.0% | 0.0% | 4 | 0 | 0.0% | Q1 2024 | May 13, 2024 |
| CITADEL ADVISORS LLC | History | New | 10,650 | 9 | 0.0% | — | 5 | +10,650 | New | Q1 2024 | May 15, 2024 |
| Tower Research Capital LLC (TRC) | History | Added to | 6,057 | 5 | 0.0% | 0.0% | 6 | +795 | 15.11% | Q1 2024 | May 15, 2024 |
| UBS Group AG | History | Closed out | 0 | 0 | — | 0.0% | — | -3,537 | -100.0% | Q4 2023 | Feb 09, 2024 |
| NATIONAL BANK OF CANADA /FI/ | History | Closed out | 0 | 0 | — | — | — | -110 | -100.0% | Q4 2023 | Feb 06, 2024 |
| WELLS FARGO & COMPANY/MN | History | Added to | 16 | 0 | — | — | — | +3 | 23.08% | Q1 2024 | May 10, 2024 |
| BANK OF AMERICA CORP /DE/ | History | No change | 1 | 0 | — | — | — | 0 | 0.0% | Q1 2024 | Mar 18, 2025 |
| MORGAN STANLEY | History | No change | 10 | 0 | — | — | — | 0 | 0.0% | Q1 2024 | Oct 17, 2024 |